World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-8nb7xf
Date of registration: 01/02/2012
Primary sponsor: UFC- Universidade Federal do Ceará - Brazil
Public title: A study that evaluates the influence of an exercise program guided and structured combined with sleep hygiene measures on the metabolic changes, sleep disturbances and quality of life in patients with type 2 diabetes.
Scientific title: A Randomized study on the effects of sleep hygiene in glycemic control in patients with type 2 diabetes mellitus - DPAF: Diabetes and Physical Activity in Fortaleza
Date of first enrolment: 01/12/2010
Target sample size: 200
Recruitment status: recruiting
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-8nb7xf/
Study type: 
Study design:  Clinical trial, randomized, open with two arms  
Countries of recruitment
Brazil
Contacts
Name: Thiago  Daniele
Address:  Rua: Prof. Costa Mendes, 1608 - 4° Andar Bloco Didático da Faculdade de Medicina / UFC Rodolfo Teófilo 60.430-140 Fortaleza - CE Brazil
Telephone: (85) 96477428 - (85) 88038150
Email: danielethiago@yahoo.com.br
Affiliation:  UFC- Universidade Federal do Ceará
Name: Thiago  Daniele
Address:  Rua: Prof. Costa Mendes, 1608 - 4° Andar Bloco Didático da Faculdade de Medicina / UFC Rodolfo Teófilo 60.430-140 Fortaleza - CE Brazil
Telephone: (85) 96477428 - (85) 88038150
Email: danielethiago@yahoo.com.br
Affiliation:  UFC- Universidade Federal do Ceará
Key inclusion & exclusion criteria
Inclusion criteria: Know diagnosed type 2 diabetes for at least 6 months.
Men and Woman.
Aged between 40 and 60 years.
Sign the consent term.


Exclusion criteria: Shift workers
Drug abuse
Hospitalization (past 30 days)
Severe comorbities (renal or hepatic impairment, advanced neoplasia, severe heart failure, severe neurological disorder)


Age minimum: 40Y
Age maximum: 60Y
Gender: -
Health Condition(s) or Problem(s) studied
E00-E90
Type 2 diabetes, disorders of sleep, daytime sleepiness, depression, restless legs syndrome and sedentarism.
C18.452.394.750.149
Intervention(s)
The experimental group will receive the study treatment guidelines regarding sleep hygiene measures. These measures are absolutely not to do naps (can negotiate 15 to 30 minutes), avoiding caffeine, nicotine and alcohol, avoid heavy meals late in the day, avoid spicy foods (remember that chocolate has caffeine, sunbathe in the morning and evening, regular bedtime hours (from 22 to 23 hours), the room is for sleeping (not to watch TV, work, etc.). your room should be pleasant, moderately quiet and pleasant temperature. Will be carried aerobic exercise for fifty minutes three times a week for a period of twelve weeks. the control group did not receive such guidance. Twelve weeks after the first assessment, patients will be reassessed with the same measurements. a blood sample will be collected between 7 and 9 hours to determine biochemical and inflammatory mediators (interleukin-1, interleukin-6, C-reactive protein, TNF-alpha, visfatin).
Primary Outcome(s)
Evaluate sleep disturbances through the validation of questionnaires (Index of Pittsburgh sleep quality, the Epworth Sleepiness Scale, Questionnaire on Restless Legs, Berlin Questionnaire, the Beck Depression Inventory, quality of life questionnaire SF-36 Questionnaire level of physical activity-IPAC) used and some inflammatory parameters (interleukin-1, interleukin-6, C-reactive protein, TNF-alpha, visfatin). in patients with type 2 diabetes in both groups by ELISA biochemical methods.
Secondary Outcome(s)
Evaluate if anthropometrical measurements as:
Body-Mass Index (BMI): weight divided by height squared
Body-fat index (TCI): the circumference of the hips (cm) -18 / height x square root of time
Conicity index (CI): Waist circumference (m) / 0.109 x ROOT (body mass / height)
Waist / Hip: Waist circumference (cm) / hip circumference (cm).
Secondary ID(s)
031.04.09
Source(s) of Monetary Support
CAPES-Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil
Secondary Sponsor(s)
CIDH- Centro Integrado de Diabetes e Hipertensão - Brazil
UFC- Universidade Federal do Ceará - Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history